This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board meeting set for Q2 and H1 unaudited results approval
JYOTIRES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 1.5 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board will meet on 5 November 2026 to approve standalone unaudited financial results for the quarter and half-year ended 30 September 2026. The statutory auditors' limited review report will also be recorded. No financial figures or other material matters are disclosed.
This is a routine meeting notice. Investors may await the results on 5 November; the filing gives no figures or clues about earnings or stock performance.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹97.67 Cr | ₹74.38 Cr | +31.3% |
| Operating profit | ₹22.00 Cr | ₹19.99 Cr | +10.1% |
| Profit after tax | ₹18.48 Cr | ₹17.15 Cr | +7.8% |
| EBITDA margin | 23.0% | 27.5% | −4.5 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.